ANAB EBITDA Growth
Anaptysbio Inc · EBITDA Growth
ANAB EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported254.08%period ending
ANAB TTM EBITDA YoY % (-176.29% → 254.08%)
Year-over-year change
High-resolution chart · PNG
ANAB ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 254.0771% | |
| 176.59% | |
| 174.6488% | |
| 96.2891% | |
| 56.9606% | |
| 44.8165% | |
| 34.0703% | |
| 3.8206% | |
| -13.101% | |
| -21.6571% | |
| -33.6757% | |
| -10.4981% | |
| -28.8633% | |
| -65.7705% | |
| -88.5245% | |
| -1,246.0587% | |
| -1,198.3752% | |
| -139.0261% | |
| -197.0893% | |
| 113.9408% | |
| 90.8226% | |
| 65.1983% | |
| 80.4307% | |
| 21.8474% | |
| -2.8932% | |
| -23.1938% | |
| -60.3731% | |
| -87.39% | |
| -81.8589% | |
| -111.0701% | |
| -113.0087% | |
| -89.2902% | |
| -130.3857% | |
| -129.5586% | |
| -687.8924% | |
| -986.9547% | |
| -785.318% | |
| -210.074% | |
| 9.1881% | |
| -2,460.6383% | |
| -151.4138% | |
| -182.3084% | |
| -176.2913% |